These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 15483737)

  • 41. The effect of trimetazidine added to maximal anti-ischemic therapy in patients with advanced coronary artery disease.
    Grabczewska Z; Białoszyński T; Szymański P; Sukiennik A; Swiatkiewicz I; Koziński M; Kochman W; Grześk G; Kubica J
    Cardiol J; 2008; 15(4):344-50. PubMed ID: 18698543
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Long-term therapy of stress angina pectoris by a single daily administration of 120 mg isosorbide dinitrate in retard form. Comparison of monotherapy and combination therapy with atenolol and nifedipine].
    Blasini R; Brügmann U; Reiniger G; Rudolph W
    Herz; 1985 Jun; 10(3):163-71. PubMed ID: 3926613
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nifedipine in unstable angina: a double-blind, randomized trial.
    Gerstenblith G; Ouyang P; Achuff SC; Bulkley BH; Becker LC; Mellits ED; Baughman KL; Weiss JL; Flaherty JT; Kallman CH; Llewellyn M; Weisfeldt ML
    N Engl J Med; 1982 Apr; 306(15):885-9. PubMed ID: 7038491
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Survival analysis techniques in angina pectoris trials.
    Bristol DR; Castellana JV
    Stat Med; 1990 Mar; 9(3):293-9. PubMed ID: 2188327
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Based upon the results of the COURAGE clinical trial, what is the best treatment for stable angina? Interview by George D. Lundberg.
    Gibbons RJ
    MedGenMed; 2007 Dec; 9(4):49. PubMed ID: 18311399
    [No Abstract]   [Full Text] [Related]  

  • 46. Sample sizes and withdrawals in clinical trials.
    Caubet JF; Stason WB; Bishop DJ; Ross SD
    Lancet; 1996 Sep; 348(9031):895. PubMed ID: 8826835
    [No Abstract]   [Full Text] [Related]  

  • 47. [Correction of metabolic disturbances in patients with stable effort angina and metabolic syndrome].
    Opolonskiĭ DV; Maksimov NI
    Kardiologiia; 2009; 49(10):41-6. PubMed ID: 19845518
    [No Abstract]   [Full Text] [Related]  

  • 48. Survival versus years of healthy life: which is more powerful as a study outcome?
    Diehr P; Patrick DL; Burke GL; Williamson J
    Control Clin Trials; 1999 Jun; 20(3):267-79. PubMed ID: 10357499
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A case study of applying text analysis to identify possible adverse drug interactions: The case of Adalat (Nifedipine).
    Gefen D; Ben-Assuli O; Shlomo N; Robertson N; Klempfner R
    Health Informatics J; 2020 Jun; 26(2):1455-1464. PubMed ID: 31635509
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Medical therapy ineffective for aiding passage of ureteric stones.
    Rees J
    Practitioner; 2015 Jun; 259(1783):7. PubMed ID: 26455112
    [No Abstract]   [Full Text] [Related]  

  • 51. Estimating survival functions from the life table.
    Gehan EA
    J Chronic Dis; 1969 Feb; 21(9):629-44. PubMed ID: 5770430
    [No Abstract]   [Full Text] [Related]  

  • 52. Sustained-release nifedipine: new indication. Angina: safer drugs are available.
    Prescrire Int; 1998 Jun; 7(35):71-3. PubMed ID: 10342920
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy of I(f) inhibition with ivabradine in different subpopulations with stable angina pectoris.
    Tendera M; Borer JS; Tardif JC
    Cardiology; 2009; 114(2):116-25. PubMed ID: 19468225
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Innovative drug delivery systems in cardiovascular medicine: nifedipine-GITS and clonidine-TTS.
    Frishman WH; Sherman D; Feinfeld DA
    Cardiol Clin; 1987 Nov; 5(4):703-16. PubMed ID: 3331321
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ACTION with nifedipine GITS (Adalat XL) provides evidence for safety and improved outcome in angina patients.
    Cardiovasc J S Afr; 2004; 15(5):249-51. PubMed ID: 15483737
    [No Abstract]   [Full Text] [Related]  

  • 56. Long-term safety of a novel antianginal agent in patients with severe chronic stable angina: the Ranolazine Open Label Experience (ROLE).
    Koren MJ; Crager MR; Sweeney M
    J Am Coll Cardiol; 2007 Mar; 49(10):1027-34. PubMed ID: 17349881
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Once-daily therapy for angina pectoris with nifedipine gastrointestinal therapeutic system. Dosing and clinical efficacy.
    Vetrovec GW
    Am J Med; 1989 Jan; 86(1A):28-32. PubMed ID: 2644830
    [TBL] [Abstract][Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.